The survival of 66 patients with retransplanted kidneys, from August 1963 to March 1973, was evaluated. The life expectancy after retransplantation is less than that after primary transplantation but the difference is mainly due to an increased early postoperative mortalify. The prognosis after retransplantation is greatly improved if the second kidney is from a related donor. The prognosis is likewise improved if a longer period of time has elapsed between the two transplantations. Surprisingly, prwious exposure to specific HL-A antigens does not worsen the prognosis for a subsequent transplanted kidney.
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M ost dialysis centers have an
excessive number of uremic patients. Since patients who have rejected their transplanted kidneys add significantly to the pool of dialysis cases, it is an important question whether, and at what time, retransplantation should be carried out. A number of publications have implied that the results after retransplantation are equivalent to those following a first procedure.'-'I This has not been our experience, as documented in this report of patient and kidney survival after retransplantation. An analysis is also presented of the contribution to the outcome of other factors, such as HL-A mismatch, time of retransplantation in relation to time of first transplantation, cause of primary graft failure, and original kidney disease.
Clinical Population
At our transplantation unit, 66 patients receiving their first renal homografts b e tween November 1962 and August 1972 have later undergone one to four retransplantations. Follow-up data are available from a few months to more than nine years after the retransplantations. The immunosuppressive treatment after retransplantation was frequently different from that used intially, since the therapy provided was dependent on the management currently under evaluation for new cases.' Also, if the patients had received ALG earlier, they usually did not receive it after retransplantation. About half of the patients underwent retransplantation without removal of the previous graft and without a period of dialysis prior to regrafting.' tion. The life survival, using the time of the first transplantation as the starting point, was superior a t all subsequent levels of follow-up to that when the date of retransplantation was accepted as the starting basis for calculation. The main difference in survival was due to a heavier mortality in the first three months after r e transplantation than during the comparable period after the primary grafting. This mortality was not a function of whether homograft nephrectomy and interval dialysis was elected versus prompt retransplantation, leaving a failing graft in situ without discontinuance of immunosuppression. By the end of three months, in cases of retransplantation, there was a gap of almost 20% and, subsequently, the differential r e mained about the same (Fig 1) . The survival after secondary transplantation was somewhat influenced by the kind of kidney that was used a t the first transplantation (Fig 2) . If the first kidney was from a related donor, the overall five-year survival after the first transplant was 15 of 27 patients (56%), but after the second transplantation, the survival after five years, calculated from the time of retransplantation, was only 21% (three of 14 patients). The poor * sults were a t least partly attributed to a heavy reliance on cadaveric kidneys for retransplantation.
Results

Accepted
When the primary kidney came from an unrelated donor, the early re-;ed idpa:ient survival after retransplantation was less than that after primary transplantation, but the later survi\-a1 figures were similar. I t is noteworthy that three of the 21 recipients wcAre given kidneys from related donors the second time; after m&e than five years following retransplantation, all three are well.
As implied, the source of the secondary kidney graft was profoundly influential in determining subsequent patient survival (Fig 3) . When the organs could be obtained from related donors, the results, while not as good as for the primary consanguineous transplantations, represented a survival better than 50% for five years. In contrast, recipients of unrelated (usually cadaveric) kidneys for retransplantation had a much poorer long-term prognosis. In this latter category, none cf 12 patients has survived four years.
The time between first and second transplantation influenced the kidney sunrival after the second transplantation (Fig 4) . The kidney survival was better the longer the time between the two graft procedures.
The kidney survival with and without knqwn specific HL-A presensitization is shown in Fig 5. There were 65 grafts that, on the basis of the antigens then identifiable, did not share HL-A antigens with a previously rejected transplant, and 18 grafts in which one (17 cases) or two (one case) antigens, clearly present in a nonprimary donor and foreign to the recipient, had been present in a donor of a previous transplant. The differences in results were not different in a statistically significant way, but if anything, it was possibly slightly advantageous to have had an HL-A presensitization. The HL-A antigens involved in the cases of presensitization were as follows: A2 in seven cases; A1 in three cases; A12 in two cases; and A3, A7, A10, A l l , W 17, W27, and Te60 in one case each (Terasaki nomenclature).
An attempt was also made to analyze whether either the cause of the first graft failure or the original disease of the patients influenced the results. These attempts proved unrewarding in the first instance because 
Comment
I t appears that the outcome of retransplantation in a group of patients having rejected their first grafts is worse than that after primary transplantation, but not to a great degree. The difference is mainly accounted for by an increased early postoperative mortality. I t is an important and interesting practical consideration that such ~a t i e n t s also have a substantially depreciated prognosis if they are returned to long-term hemodialysis."
The type of kidney used primarily has not been considered an overriding factor in the decision of whether or not to perform a retransplantation. I t has been considered justified to use kidneys of relatives for retransplantation if such are available. as the subsequent result has been superior to that wikh secondary cadaveric kidneys. The prognosis after retransplantation has been better if a long period of time elapsed after first transplantation. ~o s s i b l~ a long uninterrupted period of immunosuppressive treatment makes the recipient better able to accept a second transplant. Alternatively, patients who have b o n e chronically functioning homografts without dramatic, acute rejection episodes may represent a favorable subpopulation that has been refined by natural selection. crimination of HL-A matching in predicting the outcome after organ References transplantation.' Or if HL-A antigens are directly related to histocompatibility, there is even a possibility that specific blocking antibodies were produced as a response to the sensitizing antigen, since the results, if anything, were slightly better if there had been prior exposure to an HL-A antigen found in a nonprimary donor.
